Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-295429
Filing Date
2011-11-03
Accepted
2011-11-03 17:24:46
Documents
10
Period of Report
2011-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d249747d10k.htm 10-K 1050829
2 AMENDMENT NUMBER 5 TO THE CLINICAL TRIAL AGREEMENT d249747dex1010.htm EX-10.10 12671
3 SUBSIDIARIES d249747dex211.htm EX-21.1 1869
4 CERTIFICATION BY CEO d249747dex311.htm EX-31.1 5950
5 CERTIFICATION BY CFO d249747dex312.htm EX-31.2 6117
6 CERTIFICATION OF CEO PURSUANT TO 18. U.S.C. SECTION 1350 AS ADOPTED - 906 d249747dex321.htm EX-32.1 2935
7 CERTIFICATION OF CFO PURSUANT TO 18. U.S.C. SECTION 1350 AS ADOPTED - 906 d249747dex322.htm EX-32.2 2902
8 GRAPHIC g249747ex10_10pg3a.jpg GRAPHIC 10024
9 GRAPHIC g249747ex10_10pg3b.jpg GRAPHIC 10366
10 GRAPHIC g249747ex10_10pg3c.jpg GRAPHIC 4163
  Complete submission text file 0001193125-11-295429.txt   1118631
Mailing Address 110 CRENSHAW LAKE ROAD LUTZ FL 33548
Business Address 110 CRENSHAW LAKE ROAD LUTZ FL 33548 813-527-6969
CYTODYN INC (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-49908 | Film No.: 111178647
SIC: 2834 Pharmaceutical Preparations